Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

September 01, 2014; Volume 42,Issue 9

Short Communications

  • You have access
    Long-Term Chronic Toxicity Testing Using Human Pluripotent Stem Cell–Derived Hepatocytes
    Gustav Holmgren, Anna-Karin Sjögren, Isabel Barragan, Alan Sabirsh, Peter Sartipy, Jane Synnergren, Petter Björquist, Magnus Ingelman-Sundberg, Tommy B. Andersson and Josefina Edsbagge
    Drug Metabolism and Disposition September 2014, 42 (9) 1401-1406; DOI: https://doi.org/10.1124/dmd.114.059154
  • You have access
    Polymorphisms of CYP2D17 in Cynomolgus and Rhesus Macaques: an Evidence of the Genetic Basis for the Variability of CYP2D-Dependent Drug Metabolism
    Yasuhiro Uno, Shotaro Uehara, Sakae Kohara, Norie Murayama and Hiroshi Yamazaki
    Drug Metabolism and Disposition September 2014, 42 (9) 1407-1410; DOI: https://doi.org/10.1124/dmd.114.059220
  • You have access
    Regioselective Hydroxylation of Omeprazole Enantiomers by Bacterial CYP102A1 Mutants
    Sang Hoon Ryu, Bo-Yeon Park, So-Young Kim, Sun-Ha Park, Hyun-Jin Jung, Min Park, Ki Deok Park, Taeho Ahn, Hyung-Sik Kang and Chul-Ho Yun
    Drug Metabolism and Disposition September 2014, 42 (9) 1493-1497; DOI: https://doi.org/10.1124/dmd.114.058636

Articles

  • You have access
    Flavonoids Are Inhibitors of Human Organic Anion Transporter 1 (OAT1)–Mediated Transport
    Guohua An, Xiaodong Wang and Marilyn E. Morris
    Drug Metabolism and Disposition September 2014, 42 (9) 1357-1366; DOI: https://doi.org/10.1124/dmd.114.059337
  • You have access
    Translational Pharmacokinetic Modeling of Fingolimod (FTY720) as a Paradigm Compound Subject to Sphingosine Kinase-Mediated Phosphorylation
    Nelleke Snelder, Bart A. Ploeger, Olivier Luttringer, Donald. R. Stanski and Meindert Danhof
    Drug Metabolism and Disposition September 2014, 42 (9) 1367-1378; DOI: https://doi.org/10.1124/dmd.113.056770
  • You have access
    Evaluation of Calibration Curve–Based Approaches to Predict Clinical Inducers and Noninducers of CYP3A4 with Plated Human Hepatocytes
    J. George Zhang, Thuy Ho, Alanna L. Callendrello, Robert J. Clark, Elizabeth A. Santone, Sarah Kinsman, Deqing Xiao, Lisa G. Fox, Heidi J. Einolf and David M. Stresser
    Drug Metabolism and Disposition September 2014, 42 (9) 1379-1391; DOI: https://doi.org/10.1124/dmd.114.058602
  • You have access
    A Potential Role for Human UDP-Glucuronosyltransferase 1A4 Promoter Single Nucleotide Polymorphisms in the Pharmacogenomics of Tamoxifen and Its Derivatives
    Aleksandra K. Greer, Centdrika R. Dates, Athena Starlard-Davenport, Vineetha K. Edavana, Stacie M. Bratton, Ishwori B. Dhakal, Moshe Finel, Susan A. Kadlubar and Anna Radominska-Pandya
    Drug Metabolism and Disposition September 2014, 42 (9) 1392-1400; DOI: https://doi.org/10.1124/dmd.114.058016
  • You have access
    Calibration of In Vitro Multidrug Resistance Protein 1 Substrate and Inhibition Assays as a Basis to Support the Prediction of Clinically Relevant Interactions In Vivo
    Agnès Poirier, Anne-Christine Cascais, Urs Bader, Renée Portmann, Marie-Elise Brun, Isabelle Walter, Alexander Hillebrecht, Mohammed Ullah and Christoph Funk
    Drug Metabolism and Disposition September 2014, 42 (9) 1411-1422; DOI: https://doi.org/10.1124/dmd.114.057943
  • You have access
    Inflammatory Bowel Disease Alters Intestinal Bile Acid Transporter Expression
    Jörg Jahnel, Peter Fickert, Almuthe C. Hauer, Christoph Högenauer, Alexander Avian and Michael Trauner
    Drug Metabolism and Disposition September 2014, 42 (9) 1423-1431; DOI: https://doi.org/10.1124/dmd.114.058065
  • You have access
    Identification and Functional Characterization of Novel Nonsynonymous Variants in the Human Multidrug and Toxin Extrusion 2-K
    Kenta Nishimura, Ryosuke Ide, Takeshi Hirota, Kana Kawazu, Sho Kodama, Hiroaki Takesue and Ichiro Ieiri
    Drug Metabolism and Disposition September 2014, 42 (9) 1432-1437; DOI: https://doi.org/10.1124/dmd.114.056887
  • You have access
    Time- and NADPH-Dependent Inhibition of Cytochrome P450 3A4 by the Cyclopentapeptide Cilengitide: Significance of the Guanidine Group and Accompanying Spectral Changes
    Mirza Bojić, Luca Barbero, Hugues Dolgos, Achim Freisleben, Dieter Gallemann, Simona Riva and F. Peter Guengerich
    Drug Metabolism and Disposition September 2014, 42 (9) 1438-1446; DOI: https://doi.org/10.1124/dmd.114.059295
  • You have access
    Nicotine Pharmacokinetics in Rats Is Altered as a Function of Age, Impacting the Interpretation of Animal Model Data
    Evelyn L. Craig, Bin Zhao, Jason Z. Cui, Maria Novalen, Sharon Miksys and Rachel F. Tyndale
    Drug Metabolism and Disposition September 2014, 42 (9) 1447-1455; DOI: https://doi.org/10.1124/dmd.114.058719
  • You have access
    A Strategy for Assessing Potential Drug-Drug Interactions of a Concomitant Agent against a Drug Absorbed via an Intestinal Transporter in Humans
    Akiko Mizuno-Yasuhira, Yasuhiro Nakai, Emi Gunji, Saeko Uchida, Teisuke Takahashi, Kohnosuke Kinoshita, Shigeji Jingu, Soichi Sakai, Yoshishige Samukawa and Jun-ichi Yamaguchi
    Drug Metabolism and Disposition September 2014, 42 (9) 1456-1465; DOI: https://doi.org/10.1124/dmd.114.058305
  • You have access
    The Need for Human Breast Cancer Resistance Protein Substrate and Inhibition Evaluation in Drug Discovery and Development: Why, When, and How?
    Agnès Poirier, Renée Portmann, Anne-Christine Cascais, Urs Bader, Isabelle Walter, Mohammed Ullah and Christoph Funk
    Drug Metabolism and Disposition September 2014, 42 (9) 1466-1477; DOI: https://doi.org/10.1124/dmd.114.058248
  • You have access
    Deciding on Success Criteria for Predictability of Pharmacokinetic Parameters from In Vitro Studies: An Analysis Based on In Vivo Observations
    Khaled Abduljalil, Theresa Cain, Helen Humphries and Amin Rostami-Hodjegan
    Drug Metabolism and Disposition September 2014, 42 (9) 1478-1484; DOI: https://doi.org/10.1124/dmd.114.058099
  • You have access
    Effect of CYP2A6 Genetic Polymorphism on the Metabolic Conversion of Tegafur to 5-Fluorouracil and Its Enantioselectivity
    Ikuo Yamamiya, Kunihiro Yoshisue, Yuji Ishii, Hideyuki Yamada and Masato Chiba
    Drug Metabolism and Disposition September 2014, 42 (9) 1485-1492; DOI: https://doi.org/10.1124/dmd.114.058008
  • You have access
    Characterization of Arachidonic Acid Metabolism by Rat Cytochrome P450 Enzymes: The Involvement of CYP1As
    Ahmed A. El-Sherbeni and Ayman O.S. El-Kadi
    Drug Metabolism and Disposition September 2014, 42 (9) 1498-1507; DOI: https://doi.org/10.1124/dmd.114.057836
  • You have access
    Gut Microbiota-Mediated Drug Interactions between Lovastatin and Antibiotics
    Dae-Hyoung Yoo, In Sook Kim, Thi Kim Van Le, Il-Hoon Jung, Hye Hyun Yoo and Dong-Hyun Kim
    Drug Metabolism and Disposition September 2014, 42 (9) 1508-1513; DOI: https://doi.org/10.1124/dmd.114.058354
  • You have access
    Prediction of Organic Anion-Transporting Polypeptide 1B1- and 1B3-Mediated Hepatic Uptake of Statins Based on Transporter Protein Expression and Activity Data
    Annett Kunze, Jörg Huwyler, Gian Camenisch and Birk Poller
    Drug Metabolism and Disposition September 2014, 42 (9) 1514-1521; DOI: https://doi.org/10.1124/dmd.114.058412
  • You have access
    Hepatic, Intestinal, Renal, and Plasma Hydrolysis of Prodrugs in Human, Cynomolgus Monkey, Dog, and Rat: Implications for In Vitro–In Vivo Extrapolation of Clearance of Prodrugs
    Haruka Nishimuta, J. Brian Houston and Aleksandra Galetin
    Drug Metabolism and Disposition September 2014, 42 (9) 1522-1531; DOI: https://doi.org/10.1124/dmd.114.057372
  • You have access
    Dynamic and Coordinated Regulation of KEAP1-NRF2-ARE and p53/p21 Signaling Pathways Is Associated with Acetaminophen Injury Responsive Liver Regeneration
    Xiaomei Fan, Pan Chen, Huasen Tan, Hang Zeng, Yiming Jiang, Ying Wang, Yongtao Wang, Xiangyu Hou, Huichang Bi and Min Huang
    Drug Metabolism and Disposition September 2014, 42 (9) 1532-1539; DOI: https://doi.org/10.1124/dmd.114.059394
  • You have access
    A Useful Model Capable of Predicting the Clearance of Cytochrome P450 3A4 (CYP3A4) Substrates in Humans: Validity of CYP3A4 Transgenic Mice Lacking Their Own Cyp3a Enzymes
    Tetsuya Mitsui, Takayuki Nemoto, Taiji Miyake, Shunsuke Nagao, Kotaro Ogawa, Motohiro Kato, Masaki Ishigai and Hideyuki Yamada
    Drug Metabolism and Disposition September 2014, 42 (9) 1540-1547; DOI: https://doi.org/10.1124/dmd.114.057935
  • You have access
    Interindividual Variations in Metabolism and Pharmacokinetics of 3-(6-Methylpyridine-3-yl-sulfanyl)-6-(4H-[1,2,4]triazole-3-yl-sulfanyl)-N-(1,3-thiazole-2-yl)-2-pyridine carboxamide, a Glucokinase Activator, in Rats Caused by the Genetic Polymorphism of CYP2D1
    Takuro Hasegawa, Jun-ichi Eiki and Masato Chiba
    Drug Metabolism and Disposition September 2014, 42 (9) 1548-1555; DOI: https://doi.org/10.1124/dmd.114.058081
  • You have access
    Impact of Inflammation on Chlorpromazine-Induced Cytotoxicity and Cholestatic Features in HepaRG Cells
    Pamela Bachour-El Azzi, Ahmad Sharanek, Ziad Abdel-Razzak, Sebastien Antherieu, Houssein Al-Attrache, Camille C. Savary, Sylvie Lepage, Isabelle Morel, Gilles Labbe, Christiane Guguen-Guillouzo and André Guillouzo
    Drug Metabolism and Disposition September 2014, 42 (9) 1556-1566; DOI: https://doi.org/10.1124/dmd.114.058123
  • You have access
    Role of Multidrug Resistance–Associated Protein 4 in the Basolateral Efflux of Hepatically Derived Enalaprilat
    Brian C. Ferslew, Kathleen Köck, Arlene S. Bridges and Kim L. R. Brouwer
    Drug Metabolism and Disposition September 2014, 42 (9) 1567-1574; DOI: https://doi.org/10.1124/dmd.114.057554
  • You have access
    A Numerical Method for Analysis of In Vitro Time-Dependent Inhibition Data. Part 1. Theoretical Considerations
    Swati Nagar, Jeffrey P. Jones and Ken Korzekwa
    Drug Metabolism and Disposition September 2014, 42 (9) 1575-1586; DOI: https://doi.org/10.1124/dmd.114.058289
  • You have access
    A Numerical Method for Analysis of In Vitro Time-Dependent Inhibition Data. Part 2. Application to Experimental Data
    Ken Korzekwa, Donald Tweedie, Upendra A. Argikar, Andrea Whitcher-Johnstone, Leslie Bell, Shari Bickford and Swati Nagar
    Drug Metabolism and Disposition September 2014, 42 (9) 1587-1595; DOI: https://doi.org/10.1124/dmd.114.058297

Erratum

  • You have access
    Correction to “Enhanced Nicotine Metabolism in HIV-1–Positive Smokers Compared with HIV-Negative Smokers: Simultaneous Determination of Nicotine and its Four Metabolites in Their Plasma Using a Simple and Sensitive Electrospray Ionization Liquid Chromatography–Tandem Mass Spectrometry Technique”
    Drug Metabolism and Disposition September 2014, 42 (9) 1596-1598; DOI: https://doi.org/10.1124/dmd.114.055186err
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 42 (9)
Drug Metabolism and Disposition
Vol. 42, Issue 9
1 Sep 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Short Communications
  • Articles
  • Erratum
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics